Literature DB >> 23904827

Tumor-associated antigens in breast cancer.

Carmen Criscitiello1.   

Abstract

The targets for the immune system are antigens present on cancer cells; however, many are not cancer-specific and may also be found on normal tissues. These antigens are often products of mutated cellular genes, aberrantly expressed normal genes, or genes encoding viral proteins. Vaccines constitute an active and specific immunotherapy designed to stimulate the intrinsic antitumor immune response by presenting tumor-associated antigens expressed on normal tissues that are overexpressed on tumor cells.

Entities:  

Keywords:  Breast cancer; Tumor antigen; Vaccine

Year:  2012        PMID： 23904827      PMCID： PMC3515784          DOI： 10.1159/000342164

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


  53 in total

1.  Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells.

Authors:  Naoki Hosen; Yoshiaki Sonoda; Yusuke Oji; Takafumi Kimura; Hitoshi Minamiguchi; Hiroya Tamaki; Manabu Kawakami; Momotaro Asada; Keisuke Kanato; Mari Motomura; Masaki Murakami; Tatsuya Fujioka; Tomoki Masuda; Eui Ho Kim; Akihiro Tsuboi; Yoshihiro Oka; Toshihiro Soma; Hiroyasu Ogawa; Haruo Sugiyama
Journal:  Br J Haematol       Date:  2002-02       Impact factor: 6.998

2.  The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma.

Authors:  M von Mehren; P Arlen; J Gulley; A Rogatko; H S Cooper; N J Meropol; R K Alpaugh; M Davey; S McLaughlin; M T Beard; K Y Tsang; J Schlom; L M Weiner
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

Review 3.  Unique human tumor antigens: immunobiology and use in clinical trials.

Authors:  Giorgio Parmiani; Annamaria De Filippo; Luisa Novellino; Chiara Castelli
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

4.  Wilms tumor gene (wt1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors.

Authors:  U Maurer; E Weidmann; T Karakas; D Hoelzer; L Bergmann
Journal:  Blood       Date:  1997-11-15       Impact factor: 22.113

5.  The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction.

Authors:  Kay-Dietrich Wagner; Nicole Wagner; Anja Bondke; Benno Nafz; Bert Flemming; Heinz Theres; Holger Scholz
Journal:  FASEB J       Date:  2002-05-08       Impact factor: 5.191

6.  Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

Authors:  S K Nair; A Heiser; D Boczkowski; A Majumdar; M Naoe; J S Lebkowski; J Vieweg; E Gilboa
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

7.  Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination.

Authors:  A Tsuboi; Y Oka; H Ogawa; O A Elisseeva; H Li; K Kawasaki; K Aozasa; T Kishimoto; K Udaka; H Sugiyama
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

8.  CTL in mice immunized with human mucin 1 are MHC-restricted.

Authors:  V Apostolopoulos; B E Loveland; G A Pietersz; I F McKenzie
Journal:  J Immunol       Date:  1995-12-01       Impact factor: 5.422

9.  Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.

Authors:  V Apostolopoulos; P X Xing; I F McKenzie
Journal:  Cancer Res       Date:  1994-10-01       Impact factor: 12.701

Review 10.  The many facets of the Wilms' tumour gene, WT1.

Authors:  Peter Hohenstein; Nicholas D Hastie
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150
View more
  18 in total

1.  Immunotherapy in breast cancer - towards a new understanding of both tumor and host.

Authors:  Peter C Dubsky; Giuseppe Curigliano
Journal:  Breast Care (Basel)       Date:  2012-08       Impact factor: 2.860

2.  A Highly Effective System for Predicting MHC-II Epitopes With Immunogenicity.

Authors:  Shi Xu; Xiaohua Wang; Caiyi Fei
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

Review 3.  Adaptive immunity programmes in breast cancer.

Authors:  Frederick S Varn; David W Mullins; Hugo Arias-Pulido; Steven Fiering; Chao Cheng
Journal:  Immunology       Date:  2016-09-20       Impact factor: 7.397

4.  Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.

Authors:  Lance D Miller; Jeff A Chou; Michael A Black; Cristin Print; Julia Chifman; Angela Alistar; Thomas Putti; Xiaobo Zhou; Davide Bedognetti; Wouter Hendrickx; Ashok Pullikuth; Jonathan Rennhack; Eran R Andrechek; Sandra Demaria; Ena Wang; Francesco M Marincola
Journal:  Cancer Immunol Res       Date:  2016-04-28       Impact factor: 11.151

Review 5.  Functional genomics: paving the way for more successful cancer immunotherapy.

Authors:  Reham Ajina; Danielle Zamalin; Louis M Weiner
Journal:  Brief Funct Genomics       Date:  2019-03-22       Impact factor: 4.241

6.  Immunotherapy for Breast Cancer Treatment.

Authors:  Miganoosh Simonian; Mozhan Haji Ghaffari; Babak Negahdari
Journal:  Iran Biomed J       Date:  2021-03-08

Review 7.  Immune approaches to the treatment of breast cancer, around the corner?

Authors:  Carmen Criscitiello; Angela Esposito; Lucia Gelao; Luca Fumagalli; Marzia Locatelli; Ida Minchella; Laura Adamoli; Aron Goldhirsch; Giuseppe Curigliano
Journal:  Breast Cancer Res       Date:  2014-02-25       Impact factor: 6.466

8.  Screening and identification of the tumor-associated antigen CK10, a novel potential liver cancer marker.

Authors:  Zhaoyu Zhu; Zheng Liu; Yuchun Liu; Chunyan Wang; Ruyu Li; Hui Liu; Baohua Gu; Guodong Li; Shoutao Zhang
Journal:  FEBS Open Bio       Date:  2017-03-21       Impact factor: 2.693

9.  CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice.

Authors:  Laboni Mondal; Biswajit Mukherjee; Kaushik Das; Sanchari Bhattacharya; Debasmita Dutta; Shreyasi Chakraborty; Murari Mohan Pal; Raghuvir H Gaonkar; Mita Chatterjee Debnath
Journal:  Int J Nanomedicine       Date:  2019-10-09

Review 10.  Breast Cancer Immunotherapy: An Update.

Authors:  Issam Makhoul; Mohammad Atiq; Ahmed Alwbari; Thomas Kieber-Emmons
Journal:  Breast Cancer (Auckl)       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.